Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Cancer Metastasis Rev. 2009 Jun;28(1-2):247-63. doi: 10.1007/s10555-009-9186-7.

Osteosarcoma treatment: state of the art.

Author information

  • 1Department of Chemical and Biomolecular Engineering, University of Melbourne, Melbourne, VIC, 3010, Australia.

Abstract

Osteosarcoma (OS) is a class of cancer originating from bone, mainly afflicting children or young adults. It is the second highest cause of cancer-related death in these age groups, mainly due to development of often fatal metastasis, usually in the lungs. Survival for these patients is poor despite the aggressive use of surgery, chemotherapy, and/or radiotherapy. Thus, new effective drugs and other forms of therapy are needed. This article reviews the biology and the state of the art management of OS. New experimental drugs and potential therapies targeting molecular pathways of OS are also discussed.

PMID:
19214708
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Write to the Help Desk